Tag: MS Research

Dr. Terry Wahls: A Look At Current Research – Part 2

Dr. Terry Wahls: A Look At Current Research – Part 2

Dr. Terry Wahls: A Look At Current Research – Episode 112 – Transcript

Join us for the second part of our conversation with Dr. Terry Wahls. In this episode, we’ll hear about Dr. Wahls’ own journey with MS and how her extensive research on diet and nutrition came to be. Dr. Wahls will also explain her current research and clinical trial, The Efficacy of Diet on Quality of Life in MS.
What is the best diet to have if you have been diagnosed with MS? Is there a specific MS diet? What exactly is quality of life? These are some of the questions Dr. Wahls is hoping to answer in her new clinical study. Listen in to get the details about the research project as well as ways people living with MS can apply to get involved.
Dr. Scott Newsome’s Story: The Road From Caregiver to MS Provider and Researcher – Part 2

Dr. Scott Newsome’s Story: The Road From Caregiver to MS Provider and Researcher – Part 2

Dr. Scott Newsome’s Story: The Road From Caregiver to MS Provider and Researcher – Part 2 – Episode 97 – Transcript

Join us for the second part of our conversation with Dr. Scott Newsome. On this episode, Dr. Newsome will be back to talk about how his role as an MS caregiver has impacted his career today as an MS specialist. We’ll also learn more about what Dr. Newsome has been focusing on and his exciting current research.

As promised, learn more about the current clinical trial that Dr. Newsome is working on, the TREAT-MS Clinical Trial for Multiple Sclerosis Patients.The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial will help inform patients and the broader healthcare community on whether patients would most benefit from early, possibly more risky aggressive therapy or if starting with a less aggressive (and, often, less risky) therapy, followed by a switch if breakthrough disease activity occurs, is warranted. In addition, this study will help identify if there is a specific patient population or short-term biomarker(s) that is strongly predictive of long-term disability that can result from MS. For a deeper dive, view the Neurology Live video: Peers and Perspectives: The Induction vs. Escalation Approach to MS and the TREAT-MS Trial or you can also email TREAT-MS at treatms@jhmi.edu.

Dr. Scott Newsome’s Story: The Road From Caregiver to MS Provider and Researcher – Part 1

Dr. Scott Newsome’s Story: The Road From Caregiver to MS Provider and Researcher – Part 1

Dr. Scott Newsome’s Story: The Road From Caregiver to MS Provider and Researcher – Part 1 – Episode 92 – Transcript

Join us for this two-part conversation with Dr. Scott Newsome on his journey from being a MS caregiver to becoming a MS provider and researcher. In today’s episode, we’ll hear from Dr. Newsome about his experiences as an MS caregiver and support partner to his mother, who had multiple sclerosis during Dr. Newsome’s childhood and formative years. Dr. Newsome will share what it was like to have a parent with MS and the ultimate impact that the caregiver role had for him and his future.

Caregivers also experience MS, clearly differently than the person who carries the diagnosis but experiencing the diagnosis and their own issues, nonetheless. Caregivers can experience significant stress, lack of knowledge, fatigue, role change, role confusion, and even guilt. While they want to be the best support they can be, they do not have a roadmap or guide that tells them what to do. The role of the caregiver is often underrecognized and under-supported. MS is a “we” disease not a “me” disease. Learn more about support partner resources and upcoming programming.

Research Update: Epstein-Barr Virus and MS

Research Update: Epstein-Barr Virus and MS

Research Update: Epstein-Barr Virus and MS – Episode 65 – Transcript

Join Dr. Rosalind Kalb as she interviews Dr. Alberto Ascherio, Professor of Epidemiology and Nutrition at the Harvard School of Public Health. Alberto is a lead researcher on the correlation between Epstein-Barr Virus (EBV) and Multiple Sclerosis. In this podcast, we’ll seek to answer questions like – what are the implications for someone who already has MS? Does EBV play a role in the ongoing MS disease process? How close are we to an EBV vaccine? And what does this mean for future generations? Learn answers to these quesitons and more during our fascinating conversation.